Inventor
Harpreet Singh
Inventor
Munich, DE
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07KPeptides19%
C12NMicroorganisms or enzymes19%
G01NInvestigating or analysing materials by determining their chemical or physical properties12%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology4%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
PatentTitleYear
11,123,370Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers202111,117,941B*44 restricted peptides for use in immunotherapy against cancers and related methods202111,116,826Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers202111,117,951Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers202111,111,281B*44 restricted peptides for use in immunotherapy against cancers and related methods202111,111,280Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers202111,083,784Peptides and combination of peptides for use in immunotherapy against CLL and other cancers202111,077,171Immunotherapy against several tumors including gastrointestinal and gastric cancer202111,071,773Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers202111,065,315Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers202111,065,316Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers202111,065,314Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers202111,058,754Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers202111,058,726Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers202111,058,755A*03 restricted peptides for use in immunotherapy against cancers and related methods2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (15)· patent assignee history
2021Based in Munich, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMATICS BIOTECHNOLOGIES GMBH | 15 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Munich, DE | 15 | 2021 |